Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer
Impact of BRAF-V600E mutation on the tumour microenvironment and associated genomic alterations in colorectal cancer
New developments in the treatment of colorectal malignancies
Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer
Cancer patient symptom and physical function reporting by caregivers used as predictors of adverse clinical outcomes
War in Ukraine: Global cancer aid to support refugees
RAGNAR study evidences efficacy and safety of erdafitinib in patients with advanced FGFR+ malignancies
ASCO and WHO to collaborate on quality indicators for cancer facilities
Spotlight on global cancer control at ASCO 2022
UICC announces global coalition to increase access to essential cancer medicines in low and lower middle-income countries
ASCO 2022: Highlights and analysis
ctDNA sequencing detects outcomes for pretreated advanced gastrointestinal stromal tumour
FOLFOXIRI plus panitumumab vs mFOLFOX6/PAN for unresectable RAS and BRAF wild-type mCC